Gara Jalqabaatti › Kansarii Gallbladder
Qorannoo klinikaalii Kansarii Gallbladder Ameerikaa Keessatti hirmaatuu
Qorannoo 14 Kansarii Gallbladder f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Nashville, TNQorannoo 4
- New York City, NYQorannoo 4
- Baldwin Park, CAQorannoo 4
- Cleveland, OHQorannoo 4
- Philadelphia, PAQorannoo 3
- Birmingham, ALQorannoo 3
- Dallas, TXQorannoo 3
- Louisville, KYQorannoo 3
- Portland, ORQorannoo 3
- Los Angeles, CAQorannoo 3
- Oklahoma City, OKQorannoo 3
- Pittsburgh, PAQorannoo 3
- Houston, TXQorannoo 3
- Seattle, WAQorannoo 3
- Boston, MAQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 9
- ColoradoQorannoo 4
- ConnecticutQorannoo 3
- FloridaQorannoo 8
- IllinoisQorannoo 4
- KentuckyQorannoo 3
- MassachusettsQorannoo 4
- MichiganQorannoo 3
- MinnesotaQorannoo 3
- New YorkQorannoo 5
- North CarolinaQorannoo 4
- OhioQorannoo 7
- OklahomaQorannoo 3
- OregonQorannoo 3
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 5
- WashingtonQorannoo 3
- WisconsinQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06760819Distance-Based Exercise to Preserve Function and Prevent Disability
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07265674A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07221253DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07146646Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07780838Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT05285358Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05000294Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT06101277Integrated Cancer Repository for Cancer Research
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Namoota walitti qabaa jira
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 20-Gur-2026 · NCT04907643Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.